Literature DB >> 26148402

[POTENTIALLY FATAL LYELL SYNDROME].

Daniel Agustín Godoy, Erica Alvarez, Andrea Amigot, Mario Di Napoli, Luca Massoti.   

Abstract

Toxic epidermal necrolysis or Lyell's syndrome is a rare entity with strong compromise of immune system. It is a hypersensitivity reaction secondary to the use of specific drugs and other triggers. Erythematous lesions of bullous aspect characterize the clinical picture affecting all layers of the skin, scaly and widespread in distribution and progression. Sometimes life threatening, generate a severe inflammatory and systemic reaction with multiple organ dysfunction. Treatment encompasses three objectives: identification and suspension of triggers, general clinical support and therapy to the skin lesions. Immune therapy is controversial and not supported by solid scientific evidence. We report a case that summarizes all aspects of this potentially lethal disease.

Entities:  

Mesh:

Year:  2014        PMID: 26148402

Source DB:  PubMed          Journal:  Bol Asoc Med P R        ISSN: 0004-4849


  1 in total

1.  Cyclosporine 0.1% (Ikervis®) as a corticoid-sparing agent in Lyell syndrome with KeraKlear® keratoprosthesis.

Authors:  Miriam Rahhal-Ortuño; Alex-Samir Fernández-Santodomingo; Carla Villena-Alvarado; Emma Marín-Payá; Marina Aguilar-González; Salvador García-Delpech
Journal:  Taiwan J Ophthalmol       Date:  2020-04-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.